StockData

abrdn Life Sciences Investors (HQL) stock

HQLNYSEFiscal year ends September 30
$18.34−0.61 (-3.22%)

Close on Nov 12, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$18.95
Open
$18.81
Day's range
$18.23 – $18.81
Volume
91,730
Average volume (20 days)
108,580

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodHQLS&P 500DifferenceHQL per yearS&P 500 per year
1 month+1.9%-2.7%+4.6 pts
3 months-11.2%-1.7%−9.4 pts
Year to date+19.9%+11.9%+8.1 pts
1 year+22.2%+12.0%+10.2 pts
3 years+125.2%+78.2%+47.1 pts+31.1%+21.2%
5 years+55.4%+73.2%−17.8 pts+9.2%+11.6%
10 years+161.8%+309.6%−147.9 pts+10.1%+15.1%

Press releases

Releases abrdn Life Sciences Investors filed with the SEC as exhibits to Form 8-K or 6-K

abrdn Life Sciences Investors stock: common questions

What is abrdn Life Sciences Investors's stock price?

HQL closed at $18.34 on Nov 12, 2026, down 3.22% on the day.

Does abrdn Life Sciences Investors pay a dividend?

No. abrdn Life Sciences Investors has not paid a cash dividend over the last twelve months.

How has HQL stock performed over the past year?

Including dividends, HQL returned +22.2% over the past year, against +12.0% for the S&P 500.

See a number that looks wrong?